SEC Filing Summary

Henderson Jane, Chief Financial Officer of Apogee Therapeutics, Inc., reported a transaction on 2026-07-24 involving 15,000 shares of Common Stock. The transaction was coded as a gift (G) and disposed of (D) with a price per share of $0.00. This was a bona fide gift to a donor-advised fund. Following this transaction, Henderson Jane owns 158,371 shares of Common Stock directly.